2016
DOI: 10.1111/sji.12462
|View full text |Cite
|
Sign up to set email alerts
|

Presence of HLADR Molecules and HLADRB1 mRNA in Circulating CD4+ T Cells

Abstract: The human major histocompatibility complex class II isotype HLA-DR is currently used as an activation marker for T cells. However, whether an endogenous protein expression or a molecular acquisition accounts for the presence of HLA-DR on T cells remains undetermined and still controversial. To further characterize this phenomenon, we compared several aspects of the presence of the HLA-DR protein to the presence of associated mRNA (HLA-DRB1), focusing on human T cells from peripheral blood of healthy individual… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 61 publications
(89 reference statements)
1
11
0
Order By: Relevance
“…In the case of CD25 and CTLA-4, these two markers displayed a positive correlation for a part of the CD3+ CD4+ HLA-DR+ cells ( Figure 2 A, top panel). However, the non-uniform correlation demonstrated how the CD3+ CD4+ HLA-DR+ T cells were a heterogeneous cell population, which we have also previously observed [ 32 ]. Like CTLA-4, PD-1 has an essential role in T cell inhibition and consequently also in peripheral tolerance [ 39 , 40 ].…”
Section: Discussionsupporting
confidence: 69%
See 1 more Smart Citation
“…In the case of CD25 and CTLA-4, these two markers displayed a positive correlation for a part of the CD3+ CD4+ HLA-DR+ cells ( Figure 2 A, top panel). However, the non-uniform correlation demonstrated how the CD3+ CD4+ HLA-DR+ T cells were a heterogeneous cell population, which we have also previously observed [ 32 ]. Like CTLA-4, PD-1 has an essential role in T cell inhibition and consequently also in peripheral tolerance [ 39 , 40 ].…”
Section: Discussionsupporting
confidence: 69%
“…Initially, the CD3+ CD4+ HLA-DR+ T cells were identified ( Figure 1 A), using a fluorescence minus one (FMO)-approach [ 31 ]. As previously described, this enables a less user-biased placement of a positive gate, when a marker is expressed continuously, such as HLA-DR on CD3+ CD4+ T cells [ 32 ]. For the three culture samples, the levels of CD3+ CD4+ HLA-DR+ T cells were relatively comparable, although the fraction of these T cells was highest in the contact-dependent MLC ( Figure 1 B).…”
Section: Resultsmentioning
confidence: 99%
“…The presence of HLA-DR was not confined to activated CD4+ and CD8+ T cells [14]. Nagafuchi et al [15] studied immunophenotyping of peripheral blood mononuclear cells on RA patients with HLA-DRB1genotype and found the frequency of memory CXCR4+CD4+ T cells was significantly related to severity of disease.…”
Section: Introductionmentioning
confidence: 99%
“…The eTreg subset expresses several surface markers, including the human major histocompatibility complex class II isotype HLA‐DR 32 . HLA‐DR, which is currently used as an activation marker for T cells, 33 is associated with enhanced suppressive activity within the eTreg subset 34 …”
Section: Discussionmentioning
confidence: 99%